Pages that link to "Q40458602"

The following pages link to Anxiolytic-like activity of the mGLU2/3 receptor agonist LY354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out mice. (Q40458602):

Displaying 40 items.

• G protein-coupled receptor signalling in astrocytes in health and disease: a focus on metabotropic glutamate receptors (Q26852429) (← links)
• Better understanding of mechanisms of schizophrenia and bipolar disorder: from human gene expression profiles to mouse models (Q26866254) (← links)
• Efficacy and tolerability of an mGlu2/3 agonist in the treatment of generalized anxiety disorder (Q28241583) (← links)
• Allosteric modulation of metabotropic glutamate receptors (Q30448534) (← links)
• The role of glutamate in anxiety and related disorders (Q31029023) (← links)
• Impact of metabotropic glutamate 2/3 receptor stimulation on activated dopamine release and locomotion (Q34197072) (← links)
• In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders (Q34612242) (← links)
• Decreased striatal dopamine in group II metabotropic glutamate receptor (mGlu2/mGlu3) double knockout mice (Q34992776) (← links)
• Translating glutamate: from pathophysiology to treatment (Q35739457) (← links)
• Emotional learning and glutamate: translational perspectives (Q36363614) (← links)
• Activation of group II metabotropic glutamate receptors induces long-term depression of excitatory synaptic transmission in the substantia nigra pars reticulata (Q36566392) (← links)
• The Emerging Role of Metabotropic Glutamate Receptors in the Pathophysiology of Chronic Stress-Related Disorders (Q37172873) (← links)
• Loss of metabotropic glutamate receptor 2 escalates alcohol consumption (Q37240383) (← links)
• Role of glutamate in schizophrenia: integrating excitatory avenues of research. (Q37256709) (← links)
• Can the role of genetic factors in schizophrenia be enlightened by studies of candidate gene mutant mice behaviour? (Q37461063) (← links)
• Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists (Q37775612) (← links)
• Regulation of neuronal communication by G protein-coupled receptors (Q38484504) (← links)
• Co-Activation of Metabotropic Glutamate Receptor 3 and Beta-Adrenergic Receptors Modulates Cyclic-AMP, Long-Term Potentiation, and Disrupts Memory Reconsolidation (Q38700682) (← links)
• Developmental expression of mGlu2 and mGlu3 in the mouse brain (Q38798058) (← links)
• Altered hippocampal expression of glutamate receptors and transporters in GRM2 and GRM3 knockout mice (Q41779206) (← links)
• A temporally distinct role for group I and group II metabotropic glutamate receptors in object recognition memory (Q42589411) (← links)
• Study of novel selective mGlu2 agonist in the temporo-ammonic input to CA1 neurons reveals reduced mGlu2 receptor expression in a Wistar substrain with an anxiety-like phenotype (Q42599657) (← links)
• The role of group II metabotropic glutamate receptors in cognition and anxiety: comparative studies in GRM2(-/-), GRM3(-/-) and GRM2/3(-/-) knockout mice. (Q43058779) (← links)
• Individual contribution of metabotropic glutamate receptor (mGlu) 2 and 3 to c-Fos expression pattern evoked by mGlu2/3 antagonism. (Q45390087) (← links)
• N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder (Q46865596) (← links)
• Group II metabotropic glutamate receptors in anxiety circuitry: correspondence of physiological response and subcellular distribution (Q46941534) (← links)
• Rats with extended access to cocaine exhibit increased stress reactivity and sensitivity to the anxiolytic-like effects of the mGluR 2/3 agonist LY379268 during abstinence (Q46981687) (← links)
• Functional partnership between mGlu3 and mGlu5 metabotropic glutamate receptors in the central nervous system (Q47402524) (← links)
• Immuno-pharmacological characterization of group II metabotropic glutamate receptors controlling glutamate exocytosis in mouse cortex and spinal cord. (Q47717335) (← links)
• Involvement of group II metabotropic glutamate receptors in stress-induced behavioural sensitization (Q48308838) (← links)
• The effect of intrahippocampal injection of group II and III metobotropic glutamate receptor agonists on anxiety; the role of neuropeptide Y. (Q48355006) (← links)
• Group II metabotropic glutamate receptor interactions with NHERF scaffold proteins: Implications for receptor localization in brain (Q51065760) (← links)
• Effects of metabotropic glutamate 2/3 receptor antagonists in the stress-induced hyperthermia test in singly housed mice. (Q54667744) (← links)
• Metabotropic Glutamate2 Receptors Play a Key Role in Modulating Head Twitches Induced by a Serotonergic Hallucinogen in Mice. (Q54988063) (← links)
• Chapter 4.4 The glutamatergic system as a potential therapeutic target for the treatment of anxiety disorders (Q57513867) (← links)
• Metabotropic Approaches to Anxiety (Q60473683) (← links)
• The Role of Metabotropic Glutamate Receptors in Social Behavior in Rodents (Q64071039) (← links)
• The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/neuroprotection (Q80725712) (← links)
• (2R,6R)-hydroxynorketamine exerts mGlu2 receptor-dependent antidepressant actions (Q92339977) (← links)
• Group II metabotropic glutamate receptor blockade promotes stress resilience in mice (Q92792874) (← links)